Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase

  1. Xiaoyuan Wang*,
  2. Anthony A. Ribeiro*,
  3. Ziqiang Guan*,
  4. Soman N. Abraham, and
  5. Christian R. H. Raetz*,
  1. Departments of *Biochemistry and
  2. Pathology, Duke University Medical Center, Durham, NC 27710
  1. Contributed by Christian R. H. Raetz, December 27, 2006 (received for review October 10, 2006)

Abstract

Francisella tularensis causes tularemia, a highly contagious disease of animals and humans, but the virulence features of F. tularensis are poorly defined. F. tularensis and the related mouse pathogen Francisella novicida synthesize unusual lipid A molecules lacking the 4′-monophosphate group typically found in the lipid A of Gram-negative bacteria. LpxF, a selective phosphatase located on the periplasmic surface of the inner membrane, removes the 4′-phosphate moiety in the late stages of F. novicida lipid A assembly. To evaluate the relevance of the 4′-phosphatase to pathogenesis, we constructed a deletion mutant of lpxF and compared its virulence with wild-type F. novicida. Intradermal injection of 106 wild-type but not 108 mutant F. novicida cells is lethal to mice. The rapid clearance of the lpxF mutant is associated with a stronger local cytokine response and a greater influx of neutrophils compared with wild-type. The F. novicida mutant was highly susceptible to the cationic antimicrobial peptide polymyxin. LpxF therefore represents a kind of virulence factor that confers a distinct lipid A phenotype, preventing Francisella from activating the host innate immune response and preventing the bactericidal actions of cationic peptides. Francisella lpxF mutants may be useful for immunization against tularemia.

Footnotes

  • To whom correspondence should be addressed at:
    Box 3711, Duke University Medical Center, Durham, NC 27710.
    E-mail: raetz{at}biochem.duke.edu
  • Author contributions: X.W., S.N.A., and C.R.H.R. designed research; X.W., A.A.R., and Z.G. performed research; X.W. contributed new reagents/analytic tools; X.W., A.A.R., Z.G., S.N.A., and C.R.H.R. analyzed data; and X.W. and C.R.H.R. wrote the paper.

  • The authors declare no conflict of interest.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0611606104/DC1.

  • Abbreviation:
    TLR,
    Toll-like receptor.
« Previous | Next Article »Table of Contents